Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
30 hedge funds and large institutions have $3.97M invested in Nymox Pharmaceutical Corp in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
381% more capital invested
Capital invested by funds: $825K → $3.97M (+$3.15M)
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
30% more funds holding
Funds holding: 23 → 30 (+7)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
88% less call options, than puts
Call options by funds: $21K | Put options by funds: $182K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.25M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$85.4K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$79.8K |
| 4 |
NPC
National Planning Corporation
El Segundo,
California
|
+$25.6K |
| 5 |
Goldman Sachs
New York
|
+$24.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
Airain Ltd
St. Peter Port,
Guernsey
|
-$81.4K |
| 2 |
DIA
Denver Investment Advisors
Denver,
Colorado
|
-$59K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$31K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$17.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
27
Creative Planning
Overland Park,
Kansas
| $3K | +$2.33K | +1,000 | New |
|
28
UBS Group
Zurich,
Switzerland
| $2K | -$1.32K | -568 | -45% |
|
29
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
DIA
30
Denver Investment Advisors
Denver,
Colorado
| – | -$59K | -44,369 | Closed |
|
|
31
Citadel Advisors
Miami,
Florida
| – | -$31K | -23,076 | Closed |
|
|
DADC
32
D.A. Davidson & Co
Great Falls,
Montana
| – | +$465 | +200 | New |
|
NYMX Hedge Fund Activity: Q3 2015 in Review
30 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2015, worth a combined $3.97M — up 381% from $825K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NYMX positions and 2 closed out — a net gain of 7 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.25M. The largest seller was Airain Ltd, cutting an estimated $81.4K.
- 30 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q3 2015, up from 23 in Q2 2015.
- Funds reported $3.97M of Nymox Pharmaceutical Corp stock for Q3 2015, up 381% quarter-over-quarter.
- 9 funds opened new Nymox Pharmaceutical Corp positions in Q3 2015 and 2 closed out, a net change of +7 holders.
- The largest Nymox Pharmaceutical Corp buyer in Q3 2015 was Morgan Stanley, an estimated $1.25M added.
- The largest Nymox Pharmaceutical Corp seller in Q3 2015 was Airain Ltd, an estimated $81.4K sold.
Based on aggregated 13F filings for Q3 2015.